An Open-label Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
Clinical trial NCT05061719 · COMPLETED
Trial details
- NCT number
- NCT05061719
- Sponsor
- Intra-Cellular Therapies, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-08
- Primary completion
- 2024-10-14
- Enrollment
- 812
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.